company background image
8037 logo

China Biotech Services Holdings SEHK:8037 Voorraadrapport

Laatste prijs

HK$0.44

Marktkapitalisatie

HK$429.3m

7D

-4.3%

1Y

-30.2%

Bijgewerkt

23 Nov, 2024

Gegevens

Financiële gegevens bedrijf

China Biotech Services Holdings Limited

SEHK:8037 Voorraadrapport

Marktkapitalisatie: HK$429.3m

8037 Overzicht aandelen

China Biotech Services Holdings Limited, een investeringsholding, biedt medische laboratoriumtests en gezondheidscontrolediensten aan in de Volksrepubliek China en Hongkong. Meer informatie

China Biotech Services Holdings Limited Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor China Biotech Services Holdings
Historische aandelenkoersen
Huidige aandelenkoersHK$0.44
52 Week HoogtepuntHK$0.80
52 Week LaagHK$0.25
Bèta-0.74
11 maand verandering46.67%
3 maanden verandering60.00%
1 Jaar Verandering-30.16%
33 jaar verandering-80.87%
5 jaar verandering-64.80%
Verandering sinds IPO-96.33%

Recent nieuws en updates

China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk

Aug 12
China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk

Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio

Jun 26
Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio

Recent updates

China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk

Aug 12
China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk

Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio

Jun 26
Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio

China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%

Mar 07
China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%

Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%

Jan 18
Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%

We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger

Jan 06
We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger

Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?

Dec 09
Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?

These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely

Aug 24
These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely

A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)

Nov 05
A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)

Is China Biotech Services Holdings (HKG:8037) A Risky Investment?

Oct 13
Is China Biotech Services Holdings (HKG:8037) A Risky Investment?

What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You

Jun 28
What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You

China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger

Mar 16
China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger

China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively

Dec 01
China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively

Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive

Jul 26
Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive

China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors

Apr 05
China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors

Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital

Mar 23
Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital

Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?

Feb 23
Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?

Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)

Jan 28
Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)

What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?

Jan 11
What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?

The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested

Dec 08
The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested

Rendement voor aandeelhouders

8037HK HealthcareHK Markt
7D-4.3%-1.5%-0.6%
1Y-30.2%-27.6%9.6%

Rendement versus industrie: 8037 presteerde slechter dan de Hong Kong Healthcare -sector, die het afgelopen jaar een rendement van -27.6 % opleverde.

Rendement versus markt: 8037 presteerde slechter dan Hong Kong Market, dat het afgelopen jaar een rendement van 9.6 % opleverde.

Prijsvolatiliteit

Is 8037's price volatile compared to industry and market?
8037 volatility
8037 Average Weekly Movement18.5%
Healthcare Industry Average Movement7.9%
Market Average Movement8.9%
10% most volatile stocks in HK Market19.0%
10% least volatile stocks in HK Market4.2%

Stabiele aandelenkoers: De aandelenkoers van 8037 is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 19% ) van 8037 is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen Hong Kong.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
1996142n/acbshhk.com

China Biotech Services Holdings Limited, een investeringsholding, biedt medische laboratoriumtests en gezondheidscontrolediensten aan in de Volksrepubliek China en Hongkong. Het bedrijf is actief in zeven segmenten: Medische en gezondheidsgerelateerde diensten, immunotherapie, farmaceutische producten, effecten, verzekeringsmakelaardij, BNCT en overige segmenten. Het houdt zich ook bezig met de levering van diensten op het gebied van tumorimmuunceltherapie en gezondheidsmanagement; verkoop en distributie van gezondheidsgerelateerde en farmaceutische producten; handel in effecten; verzekeringsmakelaardij; levering van diensten op het gebied van boriumneutronenvangsttherapie; geldleningen; levering van logistieke diensten; en vastgoedbeleggingen.

China Biotech Services Holdings Limited Samenvatting

Hoe verhouden de winst en inkomsten van China Biotech Services Holdings zich tot de beurswaarde?
8037 fundamentele statistieken
MarktkapitalisatieHK$429.32m
Inkomsten(TTM)-HK$144.88m
Inkomsten(TTM)HK$62.08m

6.9x

P/S-verhouding

-3.0x

Koers/Winstverhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
8037 resultatenrekening (TTM)
InkomstenHK$62.08m
Kosten van inkomstenHK$92.19m
Brutowinst-HK$30.11m
Overige uitgavenHK$114.77m
Inkomsten-HK$144.88m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)-0.15
Brutomarge-48.50%
Nettowinstmarge-233.39%
Schuld/Eigen Vermogen Verhouding40.7%

Hoe presteerde 8037 op de lange termijn?

Bekijk historische prestaties en vergelijking